Abstract

The transcription factor brachyury (TBXT in humans) promotes epithelial-mesenchymal transition (EMT) both during gastrulation and in cancer contexts and is widely used as a marker of nascent mesoderm. In their study, Benoit Bruneau and colleagues reveal the role of TBXT dosage in early human gastrulation. To know more about their work, we spoke to the first author, Emily Bulgar, and the corresponding author, Benoit Bruneau, Professor at the Department of Pediatrics, University of California San Francisco (UCSF) and Director of the Gladstone Institute of Cardiovascular Disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.